European Companies Search Engine
State Aid (€100,000 - €500,000): Germany - Evaluation plan for the block exempted R&D tax incentive scheme "Forschungszulagengesetz" Sat15 Jan 2025 State Aid Transparency (Tax advantage or tax exemption)
Overview
Text
| Country | Germany |
| Language | German |
| Aid Measure Title | Germany - Evaluation plan for the block exempted R&D tax incentive scheme "Forschungszulagengesetz" (en: Germany — Evaluation plan for the block exempted R & D tax incentive scheme) |
| SA.Number | SA.56245 |
| Ref-no. | TM-12572409 |
| National ID | HRA 9790 |
| Beneficiary National ID Type | Handelsregisternummer |
| Name of the beneficiary | AbbVie Deutschland GmbH & Co.KG |
| Beneficiary Type | Only large enterprises |
| Region | Wiesbaden, Kreisfreie Stadt |
| Sector (NACE) | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
| Aid Instrument | Tax advantage or tax exemption |
| Objectives of the Aid | Fundamental research (Art. 25(2)(a)) |
| Date of Granting | 15/01/2025 |
| Aid element, expressed as full amount | > 100,000 - 500,000 EUR |
| Granting Authority Name | Finanzamt Wiesbaden (en: Wiesbaden Tax Office) |
| Co-finance | ✗ |
| Covid-19 | ✗ |
| Entrusted Entity | |
| Financial Intermediaries |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany.
